How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

ICH E6(R3) signals a shift in how sponsors and sites work together to manage risk, technology, and data integrity in modern clinical trials. With expanded guidance on computerized systems, data governance, and remote monitoring, sponsors are expected to take a more active role in helping sites interpret and operationalize updated GCP expectations. Clearer oversight of system access, validation, audit trails, and agreements is now essential — not just for compliance, but for trial efficiency and trust.

This resource breaks down the most impactful changes for sponsors and translates them into practical actions sites can implement today. From assessing site systems to strengthening monitoring strategies, it offers a clear path to alignment as regulatory adoption progresses.

Read on to understand how stronger collaboration can support both compliance and trial success.